- Trials with a EudraCT protocol (94)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
94 result(s) found for: Conjunctival diseases.
Displaying page 1 of 5.
EudraCT Number: 2017-001838-26 | Sponsor Protocol Number: THEA-LT0455-PIV-09/16 | Start Date*: 2017-07-26 | |||||||||||
Sponsor Name:THEA | |||||||||||||
Full Title: Comparison of NAABAK® efficacy versus FLUCON® in the treatment of moderate manifestations of allergic conjunctivitis to birch pollen in subjects exposed to birch in ALYATEC’s environmental exposure... | |||||||||||||
Medical condition: Subjects presenting moderate allergic conjunctivitis to birch pollen | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003361-25 | Sponsor Protocol Number: SHP640-303 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Shire Human Genetic Therapies, Inc. | |||||||||||||
Full Title: A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in... | |||||||||||||
Medical condition: Bacterial Conjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) EE (Completed) HU (Completed) ES (Completed) PL (Completed) AT (Completed) FR (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002439-14 | Sponsor Protocol Number: SHP640-301 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Shire Human Genetic Therapies, Inc. | |||||||||||||
Full Title: A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine... | |||||||||||||
Medical condition: Adenoviral Conjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) PL (Prematurely Ended) AT (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001642-18 | Sponsor Protocol Number: WP3 | Start Date*: 2019-12-05 |
Sponsor Name:Department of Ophthalmology, Rigshospitalet-Glostrup | ||
Full Title: Effect on the ocular surface when treating glaucoma with eye drops: an investigation of the conjunctival goblet cells | ||
Medical condition: Open angular glaucoma and ocular hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003217-20 | Sponsor Protocol Number: 15073 | Start Date*: 2016-03-23 |
Sponsor Name:University of Nottingham | ||
Full Title: Management of recurrent pterygium to prevent visual impairment(REPEAT) | ||
Medical condition: RECURRENT PTERYGIUM | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001179-35 | Sponsor Protocol Number: SW2019-2 | Start Date*: 2019-09-20 |
Sponsor Name:St. Olavs Hospital | ||
Full Title: Optimizing preoperative disinfection before ocular surgery | ||
Medical condition: Bacterial eye infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2007-005452-16 | Sponsor Protocol Number: AL0705AV | Start Date*: 2008-03-10 |
Sponsor Name:Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt | ||
Full Title: A multicentre randomised placebo-controlled, double-blind clinical trial for eval¬ua¬tion of safety and efficacy of pre-seasonal specific immunotherapy with a hypoallergenic extract of a 6 grass an... | ||
Medical condition: IgE-mediated allergic diseases including symptoms of allergic rhinoconjunctivitis, controlled allergic bronchial asthma, triggered by grass/rye pollen allergens | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: PT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-003063-34 | Sponsor Protocol Number: GSDL_DE_17 | Start Date*: 2017-12-11 | |||||||||||
Sponsor Name:Lofarma S.p.A. | |||||||||||||
Full Title: A double-blind, placebo-controlled dose-escalation study of carbamylated monomeric tree pollen drops in patients with a history of allergic rhinoconjunctivitis. | |||||||||||||
Medical condition: Treatment of tree pollen-induced allergic rhinoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002174-23 | Sponsor Protocol Number: SMART_5 | Start Date*: 2011-11-21 | |||||||||||
Sponsor Name:Lofarma S.p.A. | |||||||||||||
Full Title: A dose Finding Study of the Efficacy of LAIS Grass tablets in patients suffering from grass pollen-induced allergic rhinoconjunctivitis | |||||||||||||
Medical condition: allergic rhinoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003202-27 | Sponsor Protocol Number: FAST-TOT401-19 | Start Date*: 2020-05-20 | |||||||||||
Sponsor Name:Laboratoire Innotech Internationnal | |||||||||||||
Full Title: Assessment of the eFficacy, the onset-of-Action and the Safety of Tot'héma ® in adults with moderate iron deficiency anaemia | |||||||||||||
Medical condition: Moderate iron deficiency anaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002434-13 | Sponsor Protocol Number: 01-INSULINAGLAUCOMA-2022 | Start Date*: 2023-01-18 |
Sponsor Name:Barbara Burgos-Blasco | ||
Full Title: RANDOMIZED CLINICAL TRIAL DOUBLE BLIND (WITH BLIND EVALUATOR) TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE IN PATIENTS WITH TOPICAL HYPOTENSIVE DRUGS | ||
Medical condition: Dry eye disease in glaucoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004127-79 | Sponsor Protocol Number: STALMANSHUA | Start Date*: 2018-05-09 |
Sponsor Name:UZ Leuven | ||
Full Title: Comparison of treatment with preservative-free versus preserved dexamethasone 0.1% and diclofenac 0.1% eye drops after cataract surgery. | ||
Medical condition: Treatment after cataract surgery | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000025-35 | Sponsor Protocol Number: Al0204AV | Start Date*: 2005-04-05 |
Sponsor Name:Allergopharma Joachim Ganzer KG | ||
Full Title: A multicentre randomised placebo-controlled double-blind clinical trial for evaluation of safety and efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed allergoid preparation of... | ||
Medical condition: IgE-mediated allergic diseases including allergic rhinitis/rhinoconjunctivitis, allergic bronchial asthma (GINA I and II) triggered by birch pollen allergens | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) FI (Completed) SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005263-31 | Sponsor Protocol Number: LEVOKETO_02-2020 | Start Date*: 2021-06-02 | |||||||||||
Sponsor Name:NTC SRL | |||||||||||||
Full Title: Assessment of the effects and tolerability of RD03/2016 (Levofloxacin; Ketorolac Trometamol 0.5+0.5% w/v eye drops solution) for the treatment of bacterial conjunctivitis in adults: a multicentre, ... | |||||||||||||
Medical condition: Bacterial conjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003426-24 | Sponsor Protocol Number: GLC02-19 | Start Date*: 2020-02-13 | |||||||||||
Sponsor Name:IRCCS FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA ONLUS | |||||||||||||
Full Title: 24-hour efficacy and tolerability of the tafluprost-timolol fixed association without preservatives in glaucomatous or ocular hypertensive patients already treated with latanoprost preserved with B... | |||||||||||||
Medical condition: Glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001344-11 | Sponsor Protocol Number: CCD-GPLSCD01-03-FU | Start Date*: 2018-04-11 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: Multinational, multicenter, prospective, long-term safety and efficacy follow-up study after Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration of corneal epithelium i... | |||||||||||||
Medical condition: corneal lesions with associated moderate to severe limbal stem cell deficiency due to ocular burns | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PL (Completed) FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) NL (Ongoing) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003469-36 | Sponsor Protocol Number: THEA_HLF_1/21 | Start Date*: 2021-09-17 | ||||||||||||||||
Sponsor Name:Laboratorios Théa, S.A. | ||||||||||||||||||
Full Title: “Prospective evaluation of the efficacy and safety of topical hydrocortisone treatment on clinical signs and symptoms of dry eye disease associated with moderate meibomian gland dysfunction” | ||||||||||||||||||
Medical condition: Dry Eye (DE) and Meibomian gland dysfunction (MGD) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001849-33 | Sponsor Protocol Number: SYL040012_III | Start Date*: 2012-04-09 | |||||||||||
Sponsor Name:Sylentis S.A.U. | |||||||||||||
Full Title: DOSE FINDING CLINICAL TRIAL WITH SYL040012 TO EVALUATE THE TOLERABILITY AND EFFECT ON INTRAOCULAR PRESSURE IN SUBJECTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA | |||||||||||||
Medical condition: Ocular Hypertension or Open-Angle Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003903-79 | Sponsor Protocol Number: SYL1001_IV | Start Date*: 2017-07-24 | |||||||||||
Sponsor Name:Sylentis SAU - PharmaMar Group | |||||||||||||
Full Title: A double-masked study of SYL1001 in patients with moderate to severe dry eye disease (DED) | |||||||||||||
Medical condition: Moderate to severe dry eye disease (DED) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) PT (Completed) EE (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004515-12 | Sponsor Protocol Number: 00174 | Start Date*: 2017-03-31 |
Sponsor Name:Raimo Tuuminen | ||
Full Title: Comparison between peri- and post-operative anti-inflammatory medication in cataract surgery: a randomized clinical trial | ||
Medical condition: Cataract senilis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
